Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins
01/09/2020
The trial will enroll approximately 30,000 adult volunteers at 80 sites in the United States to evaluate if the candidate vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19).